Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × rindopepimut × CNS × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Interventional 5 Expanded_access 1

Sponsor

Cancer Type

Conditions

Interventions

3-Iodobenzylguanidine 9 vorasidenib 1 ulixertinib 1 tucatinib 1 tovorafenib 1 rindopepimut 1 pembrolizumab 1 pegfilgrastim 1 paclitaxel-Angiopep-2 conjugate 1 omburtamab I-131 1 mogamulizumab 1 mirdametinib 1 efineptakin alfa 1 carbon-11 methionine 1 avapritinib 1 Vorinostat 1 Vaccination 1 Proton Pump Inhibitors 1 Potassium Iodide 1 OKN 007 1 Methionine 1 Ketoconazole 1 Ipilimumab 1 Hydrocortisone 1 Granulocyte Colony-Stimulating Factor 1 Fenretinide 1 Eflornithine 1 Cancer Vaccines 1 Adjuvants, Immunologic 1 AZD 6244 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03068650 2017-10-18

CDX-110

Celldex Therapeutics

No longer available

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡